Journal
TRENDS IN BIOTECHNOLOGY
Volume 33, Issue 9, Pages 525-533Publisher
CELL PRESS
DOI: 10.1016/j.tibtech.2015.06.009
Keywords
piggyBac; transposon; iPSC; transgenesis; cell therapy; immunotherapy
Categories
Funding
- National Institutes Health [R01-DK093660]
- Department of Veterans Affairs [I01-BX002190, IK2-BX002797]
Ask authors/readers for more resources
DNA transposons offer an efficient nonviral method of permanently modifying the genomes of mammalian cells. The piggyBac transposon system has proven effective in genomic engineering of mammalian cells for preclinical applications, including gene discovery, simultaneous multiplexed genome modification, animal transgenesis, gene transfer in vivo achieving long-term gene expression in animals, and the genetic modification of clinically relevant cell types, such as induced pluripotent stem cells and human T lymphocytes. piggyBac has many desirable features, including seamless excision of transposons from the genomic DNA and the potential to target integration events to desired DNA sequences. In this review, we explore these recent applications and also highlight the unique advantages of using piggyBac for developing new molecular therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available